Perampanel
Indication
Partial-onset seizures with or without secondary generalised seizures
MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products
Amber level 0
Brand:
Fycompa®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Perampanel is recommended when other treatment options recommended by NICE CG137 have been tried or fully considered in the treatment of partial-onset seizures with or without secondary generalised seizures.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: